Peripheral Vascular Disease

Enrollment completed in trial of paclitaxel-loaded vascular wrap

Published in Cancer Weekly, July 6th, 2004

Angiotech Pharmaceuticals, Inc., (ANPI; ANP) announced that it has completed the enrollment of its vascular wrap study, approximately 6 months earlier than anticipated.

Patients suffering from poor blood flow to the legs often have surgery to "by-pass" the plaque that obstructs the artery. Typically a vein, artery or synthetic graft is sewn into the blocked artery in front of, and just beyond the obstruction, allowing blood flow to circumvent the diseased area.

Unfortunately, the sites where the graft is attached to the artery (called the anastomosis) are subject to scaring and narrowing (stenosis), leading once again to compromised blood flow and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-07-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry